Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 12.37% |
| 4 | Industrials | 10.61% |
| 5 | Consumer Staples | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PERY
2076
DELISTED
Perry Ellis International Inc
PERY
| $951K | ﹤0.01% |
54,518
+33,885
| +164% | +$535K |
|
2077
CSP Inc
CSPI
$78.4M
| $948K | ﹤0.01% |
272,000
+17,000
| +7% | +$60.9K |
|
|
IO
2078
DELISTED
ION Geophysical Corporation
IO
| $948K | ﹤0.01% |
14,976
-50,641
| -77% | -$3.19M |
|
|
UNIS
2079
DELISTED
Unilife Corporation
UNIS
| $947K | ﹤0.01% |
+31,985
| New | +$1M |
|
|
PNTR
2080
DELISTED
Pointer Telocation Ltd.
PNTR
| $945K | ﹤0.01% |
103,700
-947
| -0.9% | -$8.1K |
|
|
ATHN
2081
DELISTED
Athenahealth, Inc.
ATHN
| $938K | ﹤0.01% |
7,500
-258,450
| -97% | -$33.4M |
|
2082
Compass Diversified
CODI
$967M
| $935K | ﹤0.01% |
51,498
-12,954
| -20% | -$231K |
|
2083
Erie Indemnity
ERIE
$13.4B
| $931K | ﹤0.01% |
12,368
-22,720
| -65% | -$1.68M |
|
|
MOCO
2084
DELISTED
Mocon Inc
MOCO
| $928K | ﹤0.01% |
58,700
+5,800
| +11% | +$92.2K |
|
|
KATE
2085
DELISTED
Kate Spade & Company
KATE
| $927K | ﹤0.01% |
24,300
-664,795
| -96% | -$23.8M |
|
|
EDN
2086
Edenor
EDN
$1.03B
| $924K | ﹤0.01% |
73,200
-16,700
| -19% | -$164K |
|
|
GPIC
2087
DELISTED
Gaming Partners International Corporation
GPIC
| $921K | ﹤0.01% |
112,900
+800
| +0.7% | +$6.67K |
|
|
ENG
2088
DELISTED
ENGlobal Corp
ENG
| $916K | ﹤0.01% |
36,716
+19,016
| +107% | +$407K |
|
|
VXRT
2089
DELISTED
Vaxart
VXRT
| $915K | ﹤0.01% |
29,191
+18
| +0.1% | +$752 |
|
|
RRM
2090
DELISTED
RR MEDIA LTD ORD SHS (ISR)
RRM
| $909K | ﹤0.01% |
101,600
+9,000
| +10% | +$81.3K |
|
2091
Innodata
INOD
$2.06B
| $907K | ﹤0.01% |
281,700
-2,703
| -1% | -$8.21K |
|
2092
TAT Technologies
TATT
$538M
| $907K | ﹤0.01% |
123,700
+4,300
| +4% | +$33.5K |
|
2093
LCNB Corp
LCNB
$288M
| $905K | ﹤0.01% |
56,000
+37,692
| +206% | +$599K |
|
2094
Gencor Industries
GENC
$260M
| $904K | ﹤0.01% |
123,105
-795
| -0.6% | -$5.49K |
|
|
ULTR
2095
DELISTED
ULTRAPETROL (BAHAMAS) LTD COM STK
ULTR
| $903K | ﹤0.01% |
304,200
-66,400
| -18% | -$197K |
|
2096
Fortress Biotech
FBIO
$91M
| $901K | ﹤0.01% |
34,927
+8,766
| +34% | +$231K |
|
|
LMOS
2097
DELISTED
Lumos Networks Corp
LMOS
| $901K | ﹤0.01% |
62,300
-77,000
| -55% | -$1.06M |
|
2098
Seacoast Banking Corp of Florida
SBCF
$3.49B
| $900K | ﹤0.01% |
82,814
-12,619
| -13% | -$134K |
|
|
AZUR
2099
DELISTED
AZURE MIDSTREAM PARTNERS LP COM UNT LTD PARTNER INT
AZUR
| $899K | ﹤0.01% |
44,143
+9,880
| +29% | +$187K |
|
2100
Copa Holdings
CPA
$6.19B
| $898K | ﹤0.01% |
+6,300
| New | +$882K |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.